COBEA PHARMA
ActiveSummary
COBEA PHARMA has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137k and a net result of €4k. Equity is growing by ~8.3% per year across the filed fiscal years. Its solvency ranks better than 53% of 4178 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability70▼-5
Solvency63▲+3
Growth52=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 1.54 against 1.46 in 2024; short-term debt: 61.6% and cash: 35.5% of total assets), but 61.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 07-10-2025, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
37 d early
2023
27 d early
2022
19 d early
2021
27 d early
2020
11 d early
2019
29 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close25-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€4k▼ 81.2%
2024 · €19k
Working capital
€119k▲ 6.1%
2024 · €112k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€59k▲ 106%€82k▲ 39.5%€38k▼ 53.7%€29k▼ 23.8%€7k▼ 77.0%
Net result€42k▲ 146%€59k▲ 42.1%€27k▼ 54.8%€19k▼ 28.2%€4k▼ 81.2%
Equity€102k▲ 13.1%€131k▲ 28.9%€134k▲ 2.3%€133k▼ 0.5%€137k▲ 2.7%
Total assets€479k▲ 23.8%€423k▼ 11.5%€416k▼ 1.7%€378k▼ 9.3%€357k▼ 5.5%
Debt€377k▲ 27.1%€292k▼ 22.4%€282k▼ 3.5%€244k▼ 13.4%€220k▼ 10.1%
Working capital€81k▲ 18.4%€105k▲ 30.0%€109k▲ 4.2%€112k▲ 2.5%€119k▲ 6.1%
Staff (FTE)1.5=1.5=1.9▲ 26.7%1.9=1.9=
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 77% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €357k
Fixed assets
€18k ▼ 14.7%
Current assets
€338k ▼ 5.0%
Equity and liabilities €357k
Equity
€137k ▲ 2.7%
Debt
€220k ▼ 10.1%
Debt's share of the balance-sheet total falls from 64.7% to 61.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€12k▼
2024 · €47k
Cash flow
€9k▼
2024 · €38k
Current ratio
1.54▲
2024 · 1.46
Quick ratio
0.97▲
2024 · 0.94
Debt to equity
1.60▼
2024 · 1.83
ROE
2.6%▼
2024 · 14.4%
ROA
1.0%▼
2024 · 5.1%
Interest coverage
14.23▼
2024 · 22.05
Debt ≤ 1 year
€220k▼
2024 · €244k
Income taxes
€2k▼
2024 · €8k
Staff costs
€113k▲
2024 · €106k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €69k | €97k | €106k | €113k | ▲ 6.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €27k | €27k | €29k | €18k | €6k | ▼ 68.3% |
| Other operating charges640/8 | - | €643 | €2k | €2k | €3k | ▲ 74.8% |
| Non-recurring operating charges66A | - | €100 | - | - | - | - |
| Gross operating margin9900 | €151k | €179k | €167k | €156k | €129k | ▼ 17.3% |
| Operating profit (loss)9901 | €59k | €82k | €38k | €29k | €7k | ▼ 77.0% |
| Financial income75/76B | - | €147 | €231 | €5 | €343 | ▲ 6,364% |
| Recurring financial income75 | €2 | €147 | €231 | €5 | €343 | ▲ 6,364% |
| Financial charges65/66B | - | €2k | €2k | €2k | €874 | ▼ 59.2% |
| Recurring financial charges65 | €3k | €2k | €2k | €2k | €874 | ▼ 59.2% |
| Profit (loss) for the period before taxes9903 | €56k | €80k | €36k | €27k | €6k | ▼ 77.2% |
| Income taxes67/77 | €14k | €20k | €9k | €8k | €2k | ▼ 67.0% |
| Profit (loss) for the period9904 | €42k | €59k | €27k | €19k | €4k | ▼ 81.2% |
| Profit (loss) for the period to be appropriated9905 | €42k | €59k | €27k | €19k | €4k | ▼ 81.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €479k | €423k | €416k | €378k | €357k | ▼ 5.5% |
| Fixed assets21/28 | €75k | €58k | €35k | €21k | €18k | ▼ 14.7% |
| Tangible fixed assets22/27 | €75k | €58k | €35k | €21k | €18k | ▼ 14.7% |
| Plant, machinery and equipment23 | - | €4k | €3k | €6k | €7k | ▲ 9.7% |
| Furniture and vehicles24 | - | €1k | €2k | €1k | €555 | ▼ 57.2% |
| Other tangible fixed assets26 | - | €53k | €30k | €14k | €11k | ▼ 21.3% |
| Current assets29/58 | €404k | €365k | €381k | €356k | €338k | ▼ 5.0% |
| Stocks and contracts in progress3 | €107k | €105k | €112k | €125k | €126k | ▲ 0.4% |
| Stocks30/36 | - | €105k | €112k | €125k | €126k | ▲ 0.4% |
| Amounts receivable within one year40/41 | €169k | €134k | €77k | €80k | €81k | ▲ 0.1% |
| Trade receivables40 | - | €109k | €71k | €74k | €73k | ▼ 1.3% |
| Other amounts receivable41 | - | €25k | €6k | €6k | €8k | ▲ 16.2% |
| Cash at bank and in hand54/58 | €125k | €125k | €188k | €145k | €127k | ▼ 12.7% |
| Deferred charges and accrued income490/1 | - | €1k | €4k | €5k | €5k | ▲ 0.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €479k | €423k | €416k | €378k | €357k | ▼ 5.5% |
| Equity10/15 | €102k | €131k | €134k | €133k | €137k | ▲ 2.7% |
| Contributions10/11 | - | €12k | €19k | €19k | €19k | = |
| Outside capital11 | - | €12k | - | - | - | - |
| Other1109/19 | - | €12k | - | - | - | - |
| Reserves13 | €2k | €2k | €2k | €2k | €2k | = |
| Non-distributable reserves130/1 | - | €2k | €2k | - | - | - |
| Reserves not available under the articles1311 | - | €2k | €2k | - | - | - |
| Distributable reserves133 | - | - | - | €2k | €2k | = |
| Profit (loss) carried forward14 | €87k | €117k | €114k | €113k | €117k | ▲ 3.2% |
| Amounts payable17/49 | €377k | €292k | €282k | €244k | €220k | ▼ 10.1% |
| Amounts payable after more than one year17 | €54k | €32k | €10k | - | - | - |
| Financial debts170/4 | - | €32k | €10k | - | - | - |
| Amounts payable within one year42/48 | €323k | €260k | €272k | €244k | €220k | ▼ 10.1% |
| Current portion of amounts payable after more than one year42 | - | €23k | €24k | €10k | - | - |
| Trade debts44 | €259k | €179k | €202k | €195k | €197k | ▲ 1.0% |
| Suppliers440/4 | - | €179k | €202k | €195k | €197k | ▲ 1.0% |
| Taxes, remuneration and social security45 | - | €26k | €12k | €15k | €16k | ▲ 13.2% |
| Taxes450/3 | - | €12k | - | €513 | €1k | ▲ 105% |
| Remuneration and social security454/9 | - | €14k | €12k | €14k | €15k | ▲ 9.9% |
| Other amounts payable47/48 | - | €32k | €33k | €25k | €6k | ▼ 74.5% |
| Accrued charges and deferred income492/3 | - | - | €1k | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €42k | €59k | €27k | €19k | €4k | ▼ 81.2% |
| + Depreciation and write-downs630 | €27k | €27k | €29k | €18k | €6k | ▼ 68.3% |
| Operating cash flow (approximation) | €69k | €87k | €56k | €38k | €9k | ▼ 74.9% |
| Investment in fixed assets (approximation) | - | €-11k | €-7k | €-4k | €-3k | ▲ 39.0% |
| Change in cash | - | €564 | €63k | €-43k | €-18k | ▲ 57.3% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
07-10
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
31-03
Financial
Weakest financial yearnet €4k ▼81.2%
Net result drops to €4k, the lowest in the series.
2024
24-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2023
04-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2022
12-10
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
31-03
Financial
Highest result since 2019net €59k ▲42.1%
Operating result €82k, net result €59k, both a record.
2021
04-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
31-03
Financial
Equity above €100kEq €102k ▲13.1%
3 profitable years in a row build equity to €102k.
2020
20-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2019
02-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2018
02-10
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2017
22-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2016
27-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Villers-la-Ville · 1 establishment unit since 2002
Ground area
604 m²
Building footprint
133 m²
Parcel 25062F0249/00E002, Wallonia. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
PHARMACIE COBEA PHARMA
since 20022.098.856.801
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25062F0249/00E002 | Wallonia | 604 m² | 1 · 133 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Camba-Pharma
BE 0717.740.414
Gent · Eq €137,100
Pharmacies by Medi-Market Group
BE 0548.663.375
Evere · Eq €137,156
PHARMACIE DE LONZEE
BE 0832.418.069
Gembloux · Eq €136,954
Apotheek De Geyter
BE 0427.043.290
Zottegem · Eq €137,221
TANNHAUSER PHARAESCOS
BE 0838.213.226
Koekelberg · Eq €136,889
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 3,551 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-12-2001
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.